{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:47:31Z","timestamp":1791031651400,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.ijantimicag.2009.01.002","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T10:03:02Z","timestamp":1236160982000},"page":"76-81","source":"Crossref","is-referenced-by-count":25,"title":["In vitro selection of fluoroquinolone resistance in Brucella melitensis"],"prefix":"10.1016","volume":"34","author":[{"given":"N.","family":"Ravanel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gestin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.01.002_bib1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/AAC.50.1.22-33.2006","article-title":"Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies","volume":"50","author":"Falagas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1469-0691.2006.01442.x","article-title":"Quinolones for brucellosis: treating old diseases with new drugs","volume":"12","author":"Pappas","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jac\/17.4.459","article-title":"In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis","volume":"17","author":"Bosch","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01977500","article-title":"In vitro activity of ciprofloxacin against Brucella melitensis","volume":"3","author":"Gobernado","year":"1984","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/AAC.33.8.1409","article-title":"Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis","volume":"33","author":"Khan","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib8","first-page":"483","article-title":"Susceptibility of Brucella melitensis to fluoroquinolones","volume":"15","author":"Qadri","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1128\/AAC.35.9.1925","article-title":"In vitro susceptibility of Brucella melitensis to antibiotics","volume":"35","author":"Rubinstein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/AAC.43.1.194","article-title":"In vitro activities of six new fluoroquinolones against Brucella melitensis","volume":"43","author":"Trujillano-Martin","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib11","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1128\/IAI.66.5.2387-2392.1998","article-title":"Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments","volume":"66","author":"Pizarro-Cerda","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib12","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/IAI.71.3.1481-1490.2003","article-title":"Role of Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome\u2013lysosome fusion in murine macrophages","volume":"71","author":"Porte","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/26.6.841","article-title":"Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis","volume":"26","author":"Lang","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.36.1.150","article-title":"Efficacy of ciprofloxacin for treatment of Brucella melitensis infections","volume":"36","author":"Al-Sibai","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF01971279","article-title":"Use of ciprofloxacin in the treatment of brucellosis","volume":"11","author":"Doganay","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib16","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.37.9.1831","article-title":"Quinolones in treatment of human brucellosis: comparative trial of ofloxacin\u2013rifampin versus doxycycline\u2013rifampin","volume":"37","author":"Akova","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.43.5.1298","article-title":"In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs","volume":"43","author":"Akova","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/AAC.35.4.756","article-title":"Lack of effective bactericidal activity of new quinolones against Brucella spp.","volume":"35","author":"Garcia-Rodriguez","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1128\/AAC.36.5.973","article-title":"Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin","volume":"36","author":"Shasha","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib20","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.37.11.2333","article-title":"Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin","volume":"37","author":"Lang","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jac\/25.2.302","article-title":"Development of ciprofloxacin resistance in Brucella melitensis","volume":"25","author":"Al-Sibai","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1469-0691.2002.00416.x","article-title":"In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey","volume":"8","author":"Kocagoz","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2009.01.002_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkg207","article-title":"Mechanisms of quinolone action and microbial response","volume":"51","author":"Hawkey","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2009.01.002_bib24","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijantimicag.2008.03.012","article-title":"In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA","volume":"32","author":"Turkmani","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib26","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1128\/AAC.46.9.3050-3053.2002","article-title":"Functional characterization of Brucella melitensis NorMI, and efflux pump belonging to the multidrug and toxic compound extrusion family","volume":"46","author":"Braibant","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/44.6.735","article-title":"Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates","volume":"44","author":"Tavio","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib28","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/AAC.42.8.2084","article-title":"Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria","volume":"42","author":"Guillemin","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","article-title":"Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes","volume":"50","author":"Aubry","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib30","first-page":"1","article-title":"Molecular mechanisms of fluoroquinolone resistance","volume":"36","author":"Chen","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib31","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/AAC.41.12.2766","article-title":"Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics","volume":"41","author":"Waters","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2180-6-84","article-title":"Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications","volume":"6","author":"Halling","year":"2006","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.01.002_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","article-title":"Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria","volume":"19","author":"Piddock","year":"2006","journal-title":"Clin Microbiol Rev"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:52:09Z","timestamp":1589619129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0924857909000259"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.01.002","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}